DynaPulse - DynaPulse Blood Pressure Monitoring Products and Services

7/12/01
Pulse Metric Introduces DynaPulse Pathway Hemodynamic Monitoring Device

SAN DIEGO, CA - - Pulse Metric, Inc. today announced the launch of the DynaPulse Pathway hemodynamic monitoring device, which the company believes to be the world’s first and only FDA-cleared blood pressure monitoring system that also provides hemodynamic information for the evaluation of cardiac function. With the launch of this new product, critical information about the heart’s performance no longer requires an invasive procedure or expensive capital equipment, as the DynaPulse Pathway system provides clinicians with a convenient, confident assessment of the patient’s cardiac function during the course of a routine blood pressure measurement.

Manufactured by Pulse Metric, the DynaPulse Pathway system utilizes a simple upper-arm cuff to measure blood pressure values (systolic, diastolic, and mean arterial pressure) and heart rate. Using proprietary patented technology, the system is also able to calculate other critical hemodynamic parameters, including cardiac output, systemic vascular resistance, left ventricular contractility, left ventricular dP/dt, and arterial compliance/distensibility. The DynaPulse monitor has been cleared for marketing by the U.S. Food and Drug Administration, and is now commercially available.

Charles Beauchamp, M.D., Ph.D., Assistant Clinical Professor at Duke University School of Medicine and Medical Director of the Raleigh VA Outpatient Clinic, is one of the first to use the technology clinically. He stated: “This technology makes it possible to capture and assess important hemodynamic measurements on the spot, without invasive procedures or expensive equipment. It has been a powerful addition to my in-clinic practice. I find it especially useful when assessing medication choices and dose titration.” Dr. Beauchamp added, “For those physicians who want to assess and trend cardiac function easily and simply, DynaPulse offers a powerful alternative. This technology is at the vanguard of the current movement to make non-invasive hemodynamic monitoring a regular part of office-based patient management.”

Shiu-Shin Chio, Ph.D., Pulse Metric’s Chief Executive Officer, commented, “The official launch of this product represents a significant milestone for our proprietary technology. In May we announced the completion of validation studies conducted at the University of California at San Diego, in which the cardiac output data obtained from our device was well correlated with data obtained from echocardiography and invasive thermodilution methods. Now this powerful technology is immediately available to physicians worldwide, allowing the company to compete in a U.S. market that is estimated to be $23 billion and a world market that is estimated to exceed $100 billion.”

Since the company was founded in 1990, several major research centers, pharmaceutical companies, University-affiliated hospitals, and clinicians around the world have utilized DynaPulse monitors and hemodynamic analysis services, including those affiliated with Harvard Medical School, Duke University School of Medicine, The University of California at San Francisco, Harbor-UCLA Medical Center, The University of California at San Diego, the University of Pittsburgh, Tulane University, The University of Rochester, The Hull Royal Infirmary Academic Unit of Cardiology, United Kingdom, the National Taiwan University Hospital, and the PLA Central Hospital in Beijing, China.

The San Diego-based company is committed to the widespread application of its easy-to-use cardiovascular monitors and proprietary pulse waveform cardiography technology to advance the treatment and management of heart failure and other related cardiovascular diseases. Pulse Metric has been granted eight patents in support of its proprietary FDA-cleared technology.

**** PMI 071201 ****

1/06/10
DynaPulse non-invasive hemodynamic (cardiovascular) profiling – an ideal screening tool for CT scans...

6/02/08
Good news for oriental medicine practitioners: China granted patent to CVM for Chinese Pulse wave Analysis applying DynaPulse…

11/12/07
New EHP Publication: 24-hour Ambulatory Vascular Properties Study on Effects of Occupational Noise Exposure – an advanced application of DynaPulse ABPM

8/28/07
All DynaPulse product is compatible with the Windows Vista operating system

7/12/07
Overweight teens and young adults have stiffer artery – According to a study using the DynaPulse Pathway, published in JASH by researchers...

4/24/07
Dr. Delgado-Almeida presenting clinical application at 2007 IASH Meeting

4/23/07
Clinical Cardiology accepts DynaPulse Cardiac Output validation paper

12/12/06
USB-Ready 24-hour Ambulatory Blood Pressure Monitor (ABPM), DynaPulse 5000A Mini and DAC – Ideal for hypertension drug study and therapy

12/01/06
DynaPulse 5200A/Pathway and DAC used for monitoring hemodynamics in ROCK2 study – Hypertension 2006;47:1-11, by TM Seasholtz, DT O’Connor, et.al.

11/07/06
DynaPulse arterial waveform and stiffness used in the study on management of potassium (K) content in essential hypertension – A current review paper published by Dr. Delgado…

1/10/06
Link between Brachial Artery Distensibility and Cardiovascular Disease among people with and without metabolic syndrome found using DynaPulse 2000A

10/27/05
Brachial Artery vs. Coronary Artery – Endothelial Function and Calcification